Maximizing value of intellectual property portfolios in cell and gene therapies to attract investors
11 Feb 2026
Theatre 1
Roundtable
- Advantages and strategies for extending Loss of Exclusivity (LOE) beyond regulatory exclusivity
- Preparing for investor IP diligence scrutiny
- Knowing the patent landscape to proactively address freedom-to-operate inquiries
Brought to you by
Sterne, Kessler, Goldstein & Fox